All Podcast Episodes
Oncology Data Advisor® · Pain Awareness Month With NIda Khan, MD, and Joseph Kalis, PharmD, BCOP This interview features Oncology Data Advisor Fellows Forum member Dr. Nida Khan, a Medical Oncology and Palliative Care Fellow at The Ohio State University, and Editorial Board member Dr. Joseph Kalis, Ambulatory Oncology Pharmacy Specialist at the University of Colorado Health, in a multid...
Oncology Data Advisor® · Prostate Cancer Awareness Month With Ulka Vaishampayan, MD In honor of Prostate Cancer Awareness Month, Oncology Data Advisor Editorial Board Member Ulka Vaishampayan, Professor of Internal Medicine at the University of Michigan Rogel Cancer Center, sat down to discuss the importance of bringing awareness to prostate cancer, up-to-date diagnostic techniques, and...
Oncology Data Advisor® · Raising Awareness of Prostate Cancer in Transgender Women: Farnoosh Nik-Ahd and Stephen Freedland This interview in honor of Prostate Cancer Awareness Month features Dr. Stephen Freedland, Urologist at Cedars-Sinai Medical Center and Oncology Data Advisor Editorial Board Member, and Dr. Farnoosh Nik-Ahd, Urology Resident at the University of California, San Fran...
Oncology Data Advisor® · Understanding the Tumor Microenvironment for Oncology Drug Development With Jesus Garcia, PhD This interview features Jesus Garcia, PhD, a tissue and liquid biopsy expert who analyzes trial sponsors' clinical protocols and aids them in developing relevant biomarker strategies for their trials. Dr. Garcia discusses his passion for understanding the tumor microenv...
Oncology Data Advisor® · Appendix Cancer Awareness Month With Thomas Abrams, MD In honor of Appendix Cancer Awareness Month this August, Dr. Thomas Abrams, Editor-in-Chief of Oncology Data Advisor and Assistant Professor of Medicine at Harvard Medical School, sat down to explain the different subtypes and presentations of appendix cancer, factors he takes into consideration when making ...
Oncology Data Advisor® · National Immunization Awareness Month: Richa Thakur and Waqas Haque This Oncology Data Advisor Fellows Forum interview celebrates National Immunization Awareness Month, featuring Richa Thakur, MD, Hematology/Oncology (Heme/Onc) Fellow at Northwell Health, and Waqas Haque, MD, Internal Medicine Resident at New York University, in a discussion about the importance...
Oncology Data Advisor® · Investigating Epcoritamab for Follicular Lymphoma and Beyond With Reid Merryman, MD Epcoritamab, a bispecific CD20-directed CD3 T-cell engager, is currently being investigated in numerous settings for patients with non-Hodgkin lymphomas. Recently, results were presented at the European Hematology Association (EHA) Congress for Cohorts 2A and 2B of the phase 1/2 ...
Oncology Data Advisor® · Spotlighting Zolbetuximab for Gastric/Gastroesophageal Junction Adenocarcinoma: Kohei Shitara, MD In this interview from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Kohei Shitara, a Medical Oncologist at the National Cancer Center Hospital East in Japan, discusses his two abstracts investigating the efficacy of zolbetuximab in gastr...
Oncology Data Advisor® · Harnessing Precision Medicine in Oncology With Ofer Sharon, MD In this interview, Ofer Sharon, MD, the CEO of OncoHost, explains the unique opportunities for harnessing precision medicine in oncology, the unmet needs regarding biomarker development, and the potential of utilizing a multicomponent biomarker approach for understanding the mechanisms of therapy res...
Oncology Data Advisor® · Thinking Outside the Box: Integrating Wellness and Natural Medicine Into Pharmacy In this interview, Swathi Varanasi, PharmD, an integrative health pharmacist, shares her passion for incorporating wellness and natural medicine into pharmacy practice, including her pathway to studying integrative health, its specific roles for helping patients with cancer achieve...
Oncology Data Advisor® · Groundbreaking Results of Mirvetuximab Soravtansine for Ovarian Cancer With Kathleen Moore, MD Welcome to Oncology Data Advisor, a digital resource for the multidisciplinary cancer team. At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Kathleen Moore, MD, Associate Director of Clinical Research and Professor of Gynecologic Oncology at t...
Oncology Data Advisor® · Accelerated Brain Age in Survivors of Childhood Cancer With Nicholas Phillips, MD In this interview from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Nicholas Phillips, a Physician Scientist at St. Jude Children's Research Hospital, discusses his research investigating accelerated brain age and associated neurocognitive impairments e...
Oncology Data Advisor® · Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma With Thomas Hutson, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Thomas Hutson, Director of the Urologic Oncology Cancer Research and Treatment Center at Baylor Sammons Cancer Center, discusses the results of the CLEAR study, in which he and his co-inve...
Oncology Data Advisor® · Reducing Drug Waste Through Dose Rounding of Bevacizumab With Puneeth Indurlal, MD In this interview from the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting, Dr. Puneeth Indurlal, Senior Director for Care Transformation at the US Oncology Network, discusses his team's abstract regarding dose rounding of bevacizumab, the potential for minimizing...
Oncology Data Advisor® · Impact of Social Determinants of Health on TNBC Treatment With Nicholas Robert, MD In this interview from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor speaks with Dr. Nicholas Robert, Chief Medical Officer for Ontada, about his team's abstract regarding the impacts of social determinants of health on genetic testing...
Oncology Data Advisor® · Supporting Patients Through Employment Disruptions During Cancer With Michael Halpern, MD In this interview from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Michael Halpern, Medical Officer in the National Cancer Institute's Healthcare Delivery Research Program, discusses his team's study investigating the effects of employment disr...
Oncology Data Advisor® · Exploring the ARTISTRY-7 Trial of Nemvaleukin Alfa in Ovarian Cancer With Noelle Cloven, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Noelle Cloven, a Gynecologic Oncologist at the Sarah Cannon Research Institute at Texas Oncology, sat down with Oncology Data Advisor to further discuss her presentation this year encompassing ...
Oncology Data Advisor® · Hematology/Oncology Trainee Experiences During COVID-19: Samuel Kareff and Ana Velazquez Mañana This Oncology Data Advisor® Fellows Forum Interview features Dr. Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, in discussion with Dr. Ana Velazquez Mañana, an Assistant Professor of Medicine in...
Oncology Data Advisor® · Improving Outcomes for IDH1/2-Mutant Glioma in the INDIGO Study With Timothy Cloughesy, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Timothy Cloughesy, Director of the Neuro-Oncology Program at the University of California Los Angeles (UCLA), sat down to further discuss his presentation regarding the INDIGO study, of which he is ...
Oncology Data Advisor® · mCSPC: Real World Characteristics and Treatment by Disease Volume With Stephen Freedland, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Stephen Freedland, Professor of Urology at Cedars-Sinai Medical Center, sat down with Oncology Data Advisor to discuss his abstract regarding real-world characteristics and treatment by diseas...
Oncology Data Advisor® · Leveraging Community-Academic Partnerships for Latinx AYA Cancer Survivors With Stephanie Smith, MD At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Stephanie Smith, Pediatric Oncologist at Stanford Medicine, sat down with Oncology Data Advisor to discuss her research on leveraging community-academic partnerships to improve access to ...
Oncology Data Advisor® · Coping With the Uncertainty of Indolent Non-Hodgkin Lymphoma With Richard Newcomb, MD At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Richard Newcomb, Hematology/Oncology Fellow at Dana-Farber/Mass General Cancer Center, sat down with Oncology Data Advisor to elaborate on his study regarding uncertainty and coping experienced by pati...
Oncology Data Advisor® · Payment Reform Through the Enhancing Oncology Model With Lalan Wilfong, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down for a conversation with Dr. Lalan Wilfong, the Senior Vice President of Payer and Care Transformation for the US Oncology Network, to discuss his presentation concerning pa...
Oncology Data Advisor® · Finding Real-World Response End Points in NSCLC Data Sets With Janet Espirito, PharmD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Janet Espirito, PharmD, a Senior Medical Director at Ontada, sat down with Oncology Data Advisor to discuss her presentation on identifying real-world end points for assessing response in pati...
Oncology Data Advisor® · Coaching Cancer Survivors Through Digital Health: Robin Lally, PhD, and Marilyn Hammer, PhD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down for a conversation with Robin Lally, PhD, and Marilyn Hammer, PhD, co–Principal Investigators of the COACH (Comprehensive Outcomes for After-Cancer Health)...
Oncology Data Advisor® · Understanding Sexual Orientation and Gender Identity Data Collection: Mandi Pratt-Chapman, PhD At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Mandi Pratt-Chapman, Associate Center Director for Community Outreach, Engagement, and Equity at George Washington University Cancer Center, sat down with Oncology Data Advisor to discuss her ...
Oncology Data Advisor® · Molecular Analyses of Sacituzumab Govitecan in Urothelial Carcinoma With Manoj Bupathi, MD At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Manojkumar Bupathi, MD, MS, a Genitourinary (GU) Medical Oncologist at Sarah Cannon Research Institute and Rocky Mountain Cancer Centers, to talk about his two stud...
Oncology Data Advisor® · Reducing Cost of Cancer Care Through Novel Therapy Adjustment With Erica Feinberg, PharmD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Erica Feinberg, PharmD, BCPS, a Senior Clinical Data Analyst at The US Oncology Network, to discuss her poster regarding novel therapy adjustments to the Enha...
Oncology Data Advisor® · Expert Perspectives in the Management of Triple-Negative Breast Cancer:Webinar Preview, Sara Tolaney i3 Health recently hostedPathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer (TNBC): Case Explorations and Answers to FAQs, an accredited CME/NCPD webinar now available on the i3 Health website. In this video intervi...
Oncology Data Advisor® · Navigating the Fellowship Experience by Creating Opportunities in Oncology With Waqas Haque In this Oncology Data Advisor® Fellows Forum interview, member Waqas Haque, MD, an Internal Medicine Resident at New York University, shares his medical training journey, the research he has conducted as Clinical Investigator Track Resident, his plans for applying to an o...
Oncology Data Advisor® · Partnering With Patients Through Advocacy With Allison Rosen At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Allison Rosen, a colorectal cancer survivor, patient advocate, and Director of Project ECHO for the American Cancer Society. Ms. Rosen shares the story of her cancer journey, how she became invo...
Oncology Data Advisor® · The Value of Integrated Palliative Care Training During Fellowship With Richa Thakur, MD In this Oncology Data Advisor® Fellows Forum interview, Richa Thakur, MD, Hematology/Oncology Fellow at Northwell Health, speaks with Nida Khan, MD, a third-year Internal Medicine Resident who is beginning a joint Medical Oncology and Palliative Care Fellowship this July. Dr...
Oncology Data Advisor® · Results of the HERIZON-BTC-01 Trial of Zanidatamab in Biliary Tract Cancers With Shubham Pant, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Shubham Pant, Associate Professor in the Department of Medical Oncology at MD Anderson Cancer Center, presented the results of HERIZON-BTC-01, a phase 2b trial investigating zanidatamab i...
Oncology Data Advisor® · Trastuzumab Deruxtecan Safety on HER2 Expressing Solid Tumors With Funda Meric-Bernstam, MD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Funda Meric-Bernstam, the Department Chair in the Department of Vascular Cancer Therapeutics at MD Anderson Cancer Center, sat down with Oncology Data Advisor to discuss her presentation o...
Oncology Data Advisor® · Exciting New Directions for Oncology Data Advisor: Live From ASCO 2023 With Dr.Thomas Abrams At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Thomas Abrams, Editor in Chief of Oncology Data Advisor, previewed some of the latest updates on Oncology Data Advisor and the new directions that will be taken in 2023, including new...
Oncology Data Advisor® · Understanding and Improving Quality of Life for Cancer Patients Through Nursing Research Following the recent 48th Oncology Nursing Society (ONS), Terri Armstrong, the Senior Investigator and Deputy Chief of the Neuro-Oncology Branch at the National Institutes of Health (NIH), sat down with Oncology Data Advisor® to further discuss her translational research reg...
Oncology Data Advisor® · Developing Telegenetic Cancer Risk Assessment for Black Individuals With Darya Kizub, MD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Darya Kizub, Hematology-Oncology Fellow at MD Anderson Cancer Center, presented her team's research regarding a novel initiative for recruiting Black individuals to be screened for hereditary...
Oncology Data Advisor® · Expanding Global Health Education Through Video and Social Media With Yan Leyfman, MD At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor sat down with Dr. Yan Leyfman, a physician at Mount Sinai Hospital and Director and Host of MedNews Week. Dr. Leyfman explains the origin and reach of MedNews Week and how ...
Oncology Data Advisor® · Renal Cell Carcinoma Research and Shared Decision Making With Bradley McGregor, MD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® sat down with Bradley McGregor, MD, Director of Clinical Research for the Lank Center of Genitourinary Oncology at the Dana-Farber Cancer Institute, to discuss his pre...
Oncology Data Advisor® · Exploring Primary Overall Survival Results of Axicabtagene Ciloleucel in ZUMA-7: Jason Westin, MD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Jason Westin, Director of Lymphoma Clinical Research at MD Anderson Cancer Center, presented the primary overall survival analysis of the phase 3 ZUMA-7 trial investigating axicabtag...
Oncology Data Advisor® · Medical Cannabis Educational Training for Oncology Fellows With Deepa Rangacharia, MD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® sat down with Dr. Deepa Rangachari, Director of Hematology/Oncology Graduate Medical Education at Beth Israel Deaconess Medical Center, to learn more about her pres...
Oncology Data Advisor® · Social Media’s Effect on Informed Decision Making in Cancer Treatment Welcome to Oncology Data Advisor®, a digital resource for the multidisciplinary cancer team. In this podcast episode, Nina Morena, MA, PhD Candidate at McGill University, and Ari Meguerditchian, MD, Surgical Oncologist at McGill University Health Center, sit down to talk about Ms. Morena...
Oncology Data Advisor® · Exploring the Approval of Epcoritamab for Diffuse Large B-Cell Lymphoma With Reid Merryman, MD In May 2023, the FDA granted approval to epcoritamab, a CD3-redirecting, CD20-targeting bispecific antibody, for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma. Following the approval, Oncology Data Advisor® ...
Oncology Data Advisor® · HemePath Hub, a Unique Learning Opportunity: Dr. Aamir Ehsan and Dr. Bridget Herschap At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® sat down with Dr. Aamir Ehsan and Dr. Bridget Herschap from CorePath Laboratories. Dr. Ehsan and Dr. Herschap describe the HemePath Hub, a unique learning opportunity offe...
Oncology Data Advisor® · Pickles Group: Supporting Kids Impacted by Parental Cancer With Cassy Horton In this interview from the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor speaks with Cassy Horton, Executive Director of Pickles Group, a nonprofit organization supporting the social and emotional wellbeing of children whose parents have ...
Oncology Data Advisor® · Social Determinants of Health and Genetic Testing in Triple-Negative Breast Cancer: Barb Kunz, LCGC At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor® sat down with Barb Kunz, a Senior Genetic Counselor at the US Oncology Network, to talk about her research on rates of germline testing for BRCA1 and BRCA2 mutations in...
Oncology Data Advisor® · Getting to the Heart of Cardio-Oncology With Jessica Coviello, DNP, RN, ANP-BC At the 48th Annual Oncology Nursing Society (ONS) Congress, Oncology Data Advisor® spoke with Jessica Coviello, Associate Dean of Faculty Development at Cizik School of Nursing at the University of Texas, Houston. Dr. Coviello shares the importance of cardio-oncology programs to impro...
Oncology Data Advisor® · See, Hear, Feel: Cognitive Psychology and Emotional Intelligence in Medicine With Christine Ko, MD In this interview, Oncology Data Advisor® is joined by Dr. Christine Ko, Professor of Dermatology and Pathology at Yale University and host of the See, Hear, Feel podcast. Dr. Ko shares her passion for incorporating cognitive psychology and emotional intelligence i...
Oncology Data Advisor® · Applying Nursing Civility in Oncology: Susan Rux, PhD At the recent 48th Annual Oncology Nursing Society (ONS) Congress in San Antonio, Texas, Susan Rux, Director of Professional Development & Practice Innovation at Temple University, Fox Chase Cancer Center in Philadelphia, Pennsylvania, sat down with Oncology Data Advisor® to talk about nursing civility an...
Oncology Data Advisor® · The Value of Integrated Palliative Care Training During Fellowship With Richa Thakur, MD In this Oncology Data Advisor® Fellows Forum Interview, Dr. Richa Thakur, Hematology/Oncology (Heme/Onc) Fellow at Northwell Health, outlines the need for palliative care education in the oncology setting and shares valuable resources for fellows who are interested in expand...
Oncology Data Advisor® · Caring for Caregivers With Natalie McAndrew, PhD, RN, ACNS-BC, CCRN-K At the 48th Annual Oncology Nursing Society (ONS) Congress, Dr. Natalie McAndrew, Assistant Professor at the University of Wisconsin-Milwaukee, sat down with Oncology Data Advisor® to discuss her presentation on the emotional, physical, and financial challenges faced by caregivers of patients ...
At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® had the privilege of interviewing many distinguished physician, nurse, pharmacist, pathologist, and patient advocate speakers about their work and research. This playlist features video and podcast conversations on topics including shared decision making in renal cell carcinoma, nursing resea...
Oncology Data Advisor® · Additional Advances in Castration-Resistant Prostate Cancer Research: Kathleen Burns, MSN, NP At the 48th Annual Oncology Nursing Society (ONS) Congress, Kathy Burns, a Nurse Practitioner at City of Hope Comprehensive Cancer Center, sat down with Oncology Data Advisor® to discuss her presentation regarding the educational need for nurses to stay up-to-date with ...
Oncology Data Advisor® · Cancer Care Delivery Across Practice Settings: Michi Gray, RN, and Joscelyn Vanduren, ANP At the 48th Annual Oncology Nursing Society (ONS) Congress, Joscelyn Vanduren and Michele "Michi" Gray sat down with Oncology Data Advisor® to further discuss their presentation We Aren't That Different: Misconceptions in Care Delivery and Patient Outcomes Between Practice ...
Oncology Data Advisor® · Project Life and Cancer Survivorship With Lesley Glenn At the recent 48th Oncology Nursing Society (ONS) Congress, metastatic breast cancer survivor Lesley Glenn sat down with Oncology Data Advisor® to tell us about Project Life, a virtual, membership-based survivorship resource for patients around the world living with stage IV breast cancer. As well, she discu...
Oncology Data Advisor® · The Unscripted Pharmacist With Lenora Casey, OCN, BSN-RN At the 48th Annual Oncology Nursing Society (ONS) Congress, Lenora Casey, an Oncology Certified Nurse and Co-Founder of the Unscripted Pharmacist Podcast, sat down with Oncology Data Advisor® to discuss her podcast, why it is important, and why oncology clinicians and patients should listen along. O...
Oncology Data Advisor® · Exploring Hot Topics in Radiation Oncology With John Hillson, RN, BSN, OCN At the recent 48th Annual Oncology Nursing Society (ONS) Congress, John Hillson, an Oncology Certified Nurse, presented his research titled Hot Topics in Radiation Oncology, in which he and colleagues expanded upon the rapidly evolving field of radiation oncology and why it is important t...
Oncology Data Advisor® · Staying Proactive in Management of Infusion-Related Reactions With Julianna Cebollero, PharmD, BCOP For patients receiving cancer treatment, infusion-related reactions pose a significant risk and management is complicated by the lack of standardized terminology and varying risk factors. At the 48th Annual Oncology Nursing Society (ONS) Congress, Julianna Cebolle...
Oncology Data Advisor® · Highlights of ONS Congress 2023 With Maria Badillo, MSN, RN, OCN, CCRP This year's Oncology Nursing Society (ONS) Congress featured numerous thought-provoking and motivating presentations from experts in the field of oncology nursing. Maria Badillo, Research Nurse Manager at MD Anderson Cancer Center and Editorial Board Member of Oncology Data Advisor®, stopped ...
Oncology Data Advisor® · Igniting a Passion for Oncology Nursing: Cure Extraordinary Healer Award® Winner Abbey Kaler, APRN The 2023 winner of the CURE Extraordinary Healer® Award, announced at the recent Oncology Nursing Society (ONS) Congress in San Antonio, Texas, is Abbey Kaler, MS, APRN, FNP-C, Advanced Practice Registered Nurse in the Advanced Breast Cancer Program at the Univ...
Oncology Data Advisor® · Additional Advances in PI3K Inhibitor Research & Clinical Trials With Janie Metsker, RN, BSN, CN-BN Phosphatidylinositol-3-kinase (PI3K) inhibitors are effective treatment for patients with breast cancer but can be associated with significant hyperglycemia and rash. In this interview from the 48th Annual Oncology Nursing Society (ONS) Congress, Janie Metsker...
Oncology Data Advisor® · What Are Ethical Dilemmas in Research Nursing, and How Do We Manage Them? With Doyle Bosque At the 48th Oncology Nursing Society (ONS) Congress, Doyle Bosque, Director of Nursing Programs Research at MD Anderson Cancer Center, sat down with Oncology Data Advisor® to further discuss and expand upon his presentation Management of Ethical Dilemmas: The Needs of the...
Oncology Data Advisor® · Aligning Treatment Goals and Value-Based Care in Multiple Myeloma With Joseph Kalis, PharmD In this exclusive interview recorded with the Pharmacy Podcast Network, Dr. Joseph Kalis, an Ambulatory Oncology Clinical Pharmacy Specialist at the University of Colorado Health, shares an insightful preview of his continuing pharmacy education (CPE)–accredited acti...
Oncology Data Advisor® · Inspiring a Fulfilling Career in Nursing With Lauren Ghazal, PhD, FNP-BC In this interview from the Oncology Nursing Society (ONS) 2023 Congress, Oncology Data Advisor speaks with Lauren Ghazal, PhD, FNP-BC, a Family Nurse Practitioner and Post-Doctoral Research Fellow at the University of Michigan. Dr. Ghazal was honored at ONS Congress as a recipient of the 20...
Oncology Data Advisor® · Unleashing the Power of Therapy Dogs for Cancer Patients: Colleen Stoner and Diane Haley, LCSW Therapy animals can deliver profound psychological, physiological, emotional, and social benefits for patients with cancer. At the recent 48th Annual Oncology Nursing Society (ONS) Congress, Colleen Stoner, Manager of Volunteer Leaders at Pet Partners, and Diane Haley,...
Oncology Data Advisor® · Reflecting on Body Image for Women With Head and Neck Cancer: Colette Baudoin, PhD, RN In this interview from the 48th Annual Oncology Nursing Society (ONS) Congress, Oncology Data Advisor speaks with Colette Baudoin, a Clinical Instructor of Nursing at Louisiana State University's School of Nursing. Ms. Baudoin shares her research regarding the lived experience...
Oncology Data Advisor® · Validating Oncology Nursing Experience Through ONCC Certification: Tony Ellis, MSEd, CAE, ICE-CCP Recently, the Oncology Nursing Certification Corporation (ONCC) unveiled its new logo, which embraces the diversity and the passion behind oncology nursing. In this interview, Tony Ellis, MSEd, CAE, ICE-CCP, the Executive Director of ONCC, shares the features of the...
Oncology Data Advisor® · Exploring Virtual Reality for Patients With Brain Cancer: Amanda King, APNP-BC In this interview from the 48th Annual Oncology Nursing Society (ONS) Congress, Oncology Data Advisor talks with Amanda King, PhD, APNP-BC, a Nurse Scientist at the National Institutes of Health, about her innovative approach to address distress and anxiety experienced by patients wit...
Oncology Data Advisor® · Strengthening Nursing Sustainability: Amy Rettig, DNP, RN, APRN-BC At the recent 48th Oncology Nursing Society (ONS) Congress, Amy Rettig, DNP, RN, APRN-BC, sat down with Oncology Data Advisor® to discuss her presentation focused on intentional facilitated conversations to promote nursing sustainability. ...
Oncology Data Advisor® · Informed Approach to Emotional Trauma for Cancer Patients: Elizabeth Archer-Nanda and Meagan Dwyer In this interview from the 48th Oncology Nursing Society (ONS) Congress, Elizabeth Archer-Nanda, Founding Member of the Behavioral Oncology Program and Clinical Director of Advanced Practice Providers at Norton Cancer Institute, and Meagan Dwyer, a Licensed Clinica...
Oncology Data Advisor® · Bolstering Leadership Skills in Oncology Nursing: Nick Escobedo, DNP, RN At the recent 48th Oncology Nursing Society (ONS) Congress, Nick Escobedo, an Oncology Nurse and Director of Inpatient Services for Oncology at Houston Methodist Hospital in Houston, Texas, sat down with Oncology Data Advisor to discuss his presentation titled Developing New Oncology Nurse ...
Oncology Data Advisor® · How to Empower Bedside Oncology Nurses as Leaders: Tammy Triglianos, DNP, ANP-BC, AOCNP At the recent 48th Oncology Nursing Society (ONS) Congress, Tammy Triglianos, DNP, ANP-BC, AOCNP, a certified Adult Oncology Nurse Practitioner at the University of North Carolina School of Nursing, sat down to further discuss her presentation Empowering Bedside Oncology Nurs...
Oncology Data Advisor® · Staying Proficient in Managing Chronic Cancer-Related Pain: Tanya Uritsky, PharmD At the recent 48th Oncology Nursing Society (ONS) Congress, Tanya Uritsky, PharmD, the Opioid Stewardship Coordinator at the Hospital of the University of Pennsylvania, sat down with Oncology Data Advisor to discuss her presentation When Pain Holds a Grudge, Give It a Nudge! Best P...
Oncology Data Advisor® · Live Podcasts From the 2023 Oncology Nursing Society (ONS) Congress: Part 1 At the 48th Annual Oncology Nursing Society (ONS) Congress in San Antonio, Texas, Oncology Data Advisor had the privilege of interviewing many distinguished nursing speakers about their research. This ONS Congress playlist features podcast conversations on topics including the healing po...
Oncology Data Advisor® · Health Care Violence Trends And Prevention Strategies: Scott Christensen, DNP, MBA, APRN, ACNP-BC At the recent Oncology Nursing Society (ONS) Congress held in San Antonio, Texas, Oncology Data Advisor spoke with Dr. Scott Christensen, Senior Nursing Director at the University of Utah Health, about his session focusing on safety and violence in health care. Dr. ...
Oncology Data Advisor® · Piloting Melanoma Research and Local Cancer Care With Richard Carvajal, MD This interview is the first in a new series spotlighting the Oncology Data Advisor® Editorial Board, featuring Dr. Richard Carvajal, Director of Medical Oncology at Northwell Health Cancer Institute. Dr. Carvajal tells the story of how he became a melanoma researcher and shares his passio...
Oncology Data Advisor® · New and Exciting Directions in Leukemia Research: Fellows Forum With Sunil Iyer, MD Oncology Data Advisor® is excited to announce the launch of the Fellows Forum, a new resource featuring expert perspectives geared toward Hematology/Oncology Fellows. In this interview, Dr. Sunil Iyer, Chief Hematology/Oncology Fellow at the University of Miami, Florida, discusse...
Oncology Data Advisor® · Fellows Forum: A Valuable Resource for Hematology/Oncology Fellows Oncology Data Advisor® is excited to announce the launch of the Fellows Forum, a new resource featuring expert perspectives geared toward Hematology/Oncology Fellows. In this interview, Dr. Samuel Kareff, Chief Hematology/Oncology Fellow at the University of Miami's Sylvester Cancer Center, discu...
Oncology Data Advisor® · ONS Live Podcast: Staying Proficient in Managing Chronic Cancer-Related Pain Tune into this interview live from the 48th Oncology Nursing Society (ONS) Congress, in which Tanya Uritsky, the Opioid Stewardship Coordinator at the Hospital of the University of Pennsylvania, discusses her presentation When Pain Holds a Grudge, Give It a Nudge! Best Practices fo...
Oncology Data Advisor® · Creating an Informed Approach to Mental and Emotional Trauma Experienced by Cancer Patients Tune into this interview live from the 48th Oncology Nursing Society (ONS) Congress, in which Elizabeth Archer-Nanda, Founding Member of the Behavioral Oncology Program and Clinical Director of Advanced Practice Providers at Norton Cancer Institute, and Mea...
Oncology Data Advisor® · Driving Health Care Accessibility Through Acute Myeloid Leukemia Research With Ian Bouligny, MD In this interview for National Minority Health Month, Oncology Data Advisor speaks with Dr. Ian Bouligny, a third-year Hematology/Oncology Fellow at Virginia Commonwealth University (VCU) Massey Cancer Center. Dr. Bouligny shares updates on his research regarding heal...
Oncology Data Advisor® · Advocating for Equitable Care in Multiple Myeloma: With Shakira Grant, MBBS In honor of National Minority Health Month, Dr. Shakira Grant, Assistant Professor at the University of North Carolina at Chapel Hill, sat down with Oncology Data Advisor to talk about her research surrounding racial disparities faced by patients with multiple myeloma. Dr. Grant outlines...
Oncology Data Advisor® · Incorporating Patient-Reported Outcomes Into Prostate Cancer Treatment With Lisa Gudenkauf, PhD At the recent American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, Dr. Lisa Gudenkauf, an Applied Research Scientist at Moffitt Cancer Center, presented her team's research regarding the Functional Assessment of Cancer Therapy—Radionuclid...
Oncology Data Advisor™ · Do Accelerated Approvals Really Benefit Patients? With Ravi Parikh, MD, MPP Recently, Ravi Parikh, MD, MPP, an Assistant Professor of Medical Ethics and Health Policy and Medicine at the University of Pennsylvania, Perelman School of Medicine, released a research letter titled, "Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug ...
Oncology Data Advisor™ · Rare Disease Day With Thomas Abrams, MD; Maria Badillo, RN, OCN®, CCRP; and Ulka Vaishampayan, MD In honor of Rare Disease Day on February 28, the Oncology Data Advisor Editorial Board held a live panel discussion that featured updates on rare gastrointestinal cancers from Dr. Thomas Abrams, Assistant Professor of Medicine at Harvard Medical School; perspe...
Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials With Ticiana Leal, MD
Oncology Data Advisor™ · Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials With Ticiana Leal, MD Last year, Dr. Ticiana Leal, Director of the Thoracic Medical Oncology Program at Winship Cancer Institute of Emory University, recorded a continuing medical education (CME)/nursing continuing professional development (NCPD)–accredited activity titled Har...
Oncology Data Advisor™ · Investigating Brentuximab Vedotin for Advanced-Stage Hodgkin Lymphoma With Habte Yimer, MD At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Habte Yimer of Texas Oncology sat down with Oncology Data Advisor to elaborate on the promising results of brentuximab vedotin for patients with advanced-stage classical Hodgkin lymphoma, including th...
Oncology Data Advisor™ · Investigating Momelotinib for Treatment of Myelofibrosis With Srdan Verstovsek, MD, PhD At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Srdan Verstovsek, Chief of the Section for Myeloproliferative Neoplasms in the Department of Leukemia at MD Anderson Cancer Center, sat down to discuss his presentation on the results of research regardi...
Oncology Data Advisor™ · Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Ira Zackon sat down with Oncology Data Advisor to discuss his abstract regarding real-world treatment patterns and survival outcomes among patients with myelodysplastic syndromes (MDS), including ways...
Oncology Data Advisor™ · Studying Olutasidenib in Relapsed/Refractory Acute Myeloid Leukemia With Jorge Cortes, MD At the recent American Society of Hematology (ASH) Annual Meeting in New Orleans, Jorge Cortes, Director of the Georgia Cancer Center in Augusta, Georgia, sat down with Oncology Data Advisor to discuss his presentation regarding the results of a pivotal phase 2 study in w...
Oncology Data Advisor™ · Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials Just under a year ago, Beth Sandy, a Thoracic Oncology Nurse Practitioner, co-led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity, Harnessing Immunotherapy-Based Strategies For Advanced Non–Small Cell Lung Cancer (NSCLC...
Oncology Data Advisor™ · Aligning Treatment Goals and Value-Based Care in Newly Diagnosed Multiple Myeloma Multiple myeloma is a clonal plasma cell malignancy characterized by several cytogenetic alterations. Treatment planning for individual patients is complicated by factors such as age, frailty, comorbidities, eligibility for autologous stem cell transplantation, and risk stratific...
Oncology Data Advisor™ · Subsequent Treatment After CAR T-Cell Therapy in Large B-Cell Lymphoma With Armin Ghobadi, MD Recently, at the American Society of Hematology (ASH) Annual Meeting in New Orleans, Dr. Armin Ghobadi, an Associate Professor at the Washington University School of Medicine, Siteman Cancer Center, sat down with Oncology Data Advisor to enlighten us about his researc...
Oncology Data Advisor™ · Optimizing Patient Outcomes With CAR T-Cell Therapy With Ola Oluwole, MD At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Ola Oluwole of Vanderbilt University Medical Center, sat down with Oncology Data Advisor to discuss two of his abstracts on prophylactic corticosteroid use for patients receiving axicabtagene ciloleucel and the role of...
Oncology Data Advisor™ · Improving the Standard of Care for Advanced Hodgkin Lymphoma With Mitul Gandhi, MD At the recent American Society of Hematology (ASH) Annual Meeting, updated results were presented for the SGN35-027 study of brentuximab vedotin plus nivolumab and chemotherapy for advanced-stage classical Hodgkin lymphoma. One of its authors, Dr. Mitul Gandhi of Virginia Cancer...
Oncology Data Advisor™ · Additional Advances in Immune Thrombocytopenia Research and Clinical Trials In 2022, Allison Imahiyerobo, an Advanced Practice Nurse at the Englewood Health Physician Network in New Jersey, led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity with i3 Health, New Insights and Avenues for Improved Patient ...
Oncology Data Advisor™ · Updates on Trials of Zilovertamab and Brentuximab Vedotin in Lymphomas With Hun Lee, MD At the recent American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor met with Dr. Hun Lee of MD Anderson to discuss the two abstracts that he presented there. Dr. Lee provided an update on the promising data for zilovertamab plus ibrutinib for patients w...
Oncology Data Advisor™ · Association of Socioeconomic Status With Adherence and Survival in Myeloma: Leon Bernal-Mizrachi, MD At the recent American Society of Hematology (ASH) Annual Meeting in New Orleans, Leon Bernal-Mizrachi, MD, an Associate Professor of Medicine in the Department of Hematology and Oncology at the Emory University School of Medicine, sat down with Oncology Data A...
Oncology Data Advisor™ · Advancing the Careers of Women in Hematology With Ariela Marshall, MD At the recent American Society of Hematology (ASH) Annual Meeting, Ariela Marshall, MD, Director of the Women's Hemostasis and Thrombosis Program and Associate Professor of Clinical Medicine at Penn Medicine, sat down with Oncology Data Advisor to talk about the ASH Women in Hematology Worki...
Oncology Data Advisor™ · Factors Leading to Black Patient Disparities in Hematology Trials With Shakira Grant, MBBS At the recent American Society of Hematology (ASH) Annual Meeting, Shakira J. Grant, MBBS, an Assistant Professor of Medicine at the University of North Carolina at Chapel Hill, sat down with Oncology Data Advisor to discuss her research she presented, "If You Don't Trus...